Choreo LLC acquired a new stake in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) during the fourth quarter, according to the company in its most recent filing with the ...

Dr David Tovey, Editor-in-Chief, Cochrane, said: "We now have the most robust, comprehensive review on 'neuraminidase inhibitors' that exists. Initially thought to reduce hospitalisations and ...

Roche is hoping the new drug can breathe new life into its flu franchise, represented by older neuraminidase inhibitor Tamiflu (oseltamivir). That was a $3 billion brand at its peak, but has ...

Mar. 1, 2024 — Researchers have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored 'dark side' of the neuraminidase (NA ...